User: prashantiyengar Topic: IP
Category: drugs :: india
Last updated: Nov 19 2014 07:06 IST RSS 2.0
 
1 to 20 of 2,468    
Govt’s engagement with MNCs on patent protection keeps domestic industry on edge 19.11.2014 TOI: India Business
The government's intention to engage with multinational companies and patent lawyers to discuss protection and enforcement of intellectual property rights in India has triggered concerns from the civil society, local firms and those advocating affordable medicines.
Also found in: [+]
Ranbaxy sues FDA for revoking approvals 19.11.2014 Telegraph: Business
Ranbaxy Laboratories has sued the US Food and Drug Administration (FDA) for revoking approvals to launch the generic versions of AstraZeneca's heartburn pill Nexium and Roche AG's anti-viral drug Valcyte.
Also found in: [+]
IPR policy and India's competitiveness (Column: Active Voice) 18.11.2014 Sify Finance
's current Intellectual Property Rights (IPR) regime is at the cusp of a major
Also found in: [+]
Foreign drug makers urge government to review IPR think tank 18.11.2014 ET: Pharma
A similar point has also been raised by the US biotech groupings PhRMA and BIO in their submissions to the US Trade Representative's office.
Also found in: [+]
Government holding IP conference with MNCs, their lawyers, excluding civil society, academics 17.11.2014 India News, Latest News in India, Live News India, India Breaking News - Times of India
The government of India claims to seek balance of public and private interests in intellectual property ...
Also found in: [+]
Drug makers alter US strategy 17.11.2014 Telegraph: Business
Mumbai, Nov. 16: Domestic pharmaceutical companies are focusing on strong products from their existing portfolio to drive growth in the face of delay in approvals for new generic drug applications by the US Food and Drug Administration (FDA).
Also found in: [+]
Alarm rings on drug patent meetings 16.11.2014 Telegraph: Nation
New Delhi, Nov. 15: An Indian consortium of health activists has expressed concern that an American organisation representing large pharmaceutical corporations plans to meet Indian patent controllers and visit the Supreme Court and Delhi High Court next week.
Also found in: [+]
Group writes to SC, HC CJs against US patent body 16.11.2014 India News, Latest News in India, Live News India, India Breaking News - Times of India
The IPOA delegation comprises representatives of pharma MNCs with interests in India and the law firms that represent them in patent disputes before the IPAB and Indian ...
Also found in: [+]
Appeal to chief justices to cancel meetings with US patent lobby 15.11.2014 TOI: India
The Campaign for Affordable Transtuzumab, a group of individuals and organisations fighting to increase access to medicines, has written to the chief justices of the Supreme Court and the Delhi Court and to the chairperson of the Intellectual Property Appellate Board (IPAB) expressing grave concern over the meetings scheduled by the US lobby group, Intellectual Property Owners Association (IPOA) with IPAB, a quasi-judicial body, the Delhi High Court and the offices of the Controller of ...
Also found in: [+]
US patent lobby to meet Indian judiciary, patent officials: Conflict of interest? 13.11.2014 TOI: India
In a glaring instance of conflict of interest many pharmaceutical MNC representatives from the US will be meeting members of judicial tribunals and higher judiciary and officers who are dealing with intellectual property (IP) cases of these companies on a visit to India next ...
Also found in: [+]
India, US IPR dialogue to begin this month 12.11.2014 Sify Finance
The US seems to be subtly upping the ante against India on intellectual property rights (IPR). While the US has launched the out-of-cycle-reviews, or OCR, under Special 301 Report, it will also pursue
Also found in: [+]
NRIs filed 78% of the patent pleas in India 7.11.2014 TOI: India
India registered the third highest rate for patent filings by non-residents at 78% of the total applications, ahead of China at 18%, Japan at 16% and the US at 50%, the latest data from the Indian patent office ...
Also found in: [+]
Ranbaxy's troubled units stand in the way of big profits 6.11.2014 Sify Finance
* Nexium went off patent in May this year
Also found in: [+]
Multinational companies back India's patent regime 3.11.2014 Rediff: Business
Multinational organizations including PepsiCo and industry associations like IPA, have come in favour of India's intellectual property regime, which is being reviewed by the US administration.
Also found in: [+]
MNCs ,other organisations, like Pepsi, IPA back India's IP regime 3.11.2014 ET: Policy
In its submission to US Trade Representative, Indian Pharmaceutical Alliance (IPA) said complaints against Indian patent regime ought to be viewed .
Also found in: [+]
Indra Nooyi-headed Pepsi-Co backs India's much-disputed Intellectual Property Rights 3.11.2014 ET: Policy
Indra Nooyi-headed Pepsi-Co has backed India’s regime of intellectual property rights, it said in comments to the US Trade Representative.
Also found in: [+]
Cipla-Novartis patent row: DIPP looking into merit of case 2.11.2014 ET: Pharma
Novartis merely imports a negligible quantity of these products manufactured in Switzerland as per its own data filed before the Patent office.
Also found in: [+]
Roche-Cipla patent row mediation fails 31.10.2014 TOI: India Business
Efforts to end the long and bitter patent tussle between domestic pharma company Cipla and multinational Roche over a lung cancer drug have come to a naught, with the Delhi high court-appointed mediator submitting its “failure” report in the case.
Also found in: [+]
Cipla asks government to revoke Novartis' patent; launches its drug 30.10.2014 ET: Pharma
Cipla has launched low-cost generic version of Novartis's respiratory drug Indacaterol while asking government to revoke patents over the medicine.
Also found in: [+]
Cipla asks government to revoke Novartis patents on respiratory drug 30.10.2014 Sify Finance
Also found in: [+]
1 to 20 of 2,468